SIGA Technologies
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 E 62nd St, New York City, New York, 1...Phone Number
(212) 672-9100Website
www.siga.comRevenue
$93.8 MillionStock Symbol
SIGAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About SIGA Technologies
SIGA Technologies, Inc. engages in the development and commercialization of solutions for unmet medical needs and biothreats in the United States. Its lead product is TPOXX, an orally administered antiviral drug for treating orthopoxvirus infections. SIGA Technologies, Inc. was founded in 1995 and is headquartered in New York, New...Explore more
SIGA Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SIGA Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SIGA Technologies recently announced quarterly report
Funding: Get notified immidiatlly once SIGA Technologies has new funding data
Check out if SIGA Technologies is spiking on competitors!
Product Launch: Get notified when SIGA Technologies launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at SIGA Technologies
Check if SIGA Technologies has recently received funding, and reach out quickly before it becomes old news!
Click to see if SIGA Technologies had a recent Job posting/layoffs
SIGA Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to SIGA Technologies
Compare insights from companies similar to SIGA Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SIGA Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SIGA Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SIGA Technologies.
SIGA Technologies financials insights
Gather financial insights about SIGA Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$12.5M
SIGA Technologies Tech Stack
A closer look at the technologies used by SIGA Technologies
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Person-Based
Product Management, Forecasting
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
SIGA Technologies News & Media
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 7, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.SIGA Declares Special Cash Dividend of $0.60 Per Share
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company’s common stock. The amount of this dividend is consistent with the level of the special dividend declared in April 2025. The dividend is payable on April 23, 2026, to shareholders of record at the close of business onSIGA Technologies (SIGA) Is Down 9.3% After Mixed 2025 Results and New Biodefense Contract Wins
SIGA Technologies, Inc. recently reported its fourth quarter and full-year 2025 results, with full-year revenue of US$94.57 million and net income of US$23.28 million, but a sharp year-on-year drop in quarterly revenue to US$3.8 million and a quarterly net loss of US$5.4 million. Alongside these results, SIGA highlighted a strong cash position of about US$155 million with no debt, fresh BARDA funding of US$27 million, and a new multi-year international oral TPOXX order of US$13SIGA Technologies Inc (SIGA) Q4 2025 Earnings Call Highlights: Strong Financial Performance and ...
SIGA Technologies Inc (SIGA) reports robust revenues and maintains a solid cash position, while exploring strategic opportunities for future growth.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding SIGA Technologies
Sign Up For FreeTo access detailed company insights
SIGA Technologies, Inc. engages in the development and commercialization of solutions for unmet medical needs and biothreats in the United States. Its lead product is TPOXX, an orally administered antiviral drug for treating orthopoxvirus infections. SIGA Technologies, Inc. was founded in 1995 and is headquartered in New York, New...... Read More
